Wells Fargo & Company Homology Medicines, Inc. Transaction History

Wells Fargo & Company

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.53 - $1.14 $6 - $14	13 Added 0.77%	1,698 $1,000
Q3 2023 Nov 13, 2023	SELL	$0.84 - $1.43 $393 - $670	-469 Reduced 21.77%	1,685 $1,000
Q2 2023 Aug 15, 2023	BUY	$0.83 - $1.12 $0 - $1	1 Added 0.05%	2,154 $1,000
Q1 2023 May 12, 2023	BUY	$0.91 - $1.69 $730 - $1,357	803 Added 59.48%	2,153 $2,000
Q4 2022 Feb 13, 2023	SELL	$1.09 - $2.04 $755 - $1,413	-693 Reduced 33.92%	1,350 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $175 - $340	113 Added 5.85%	2,043 $3,000
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $84,178 - $188,947	-60,560 Reduced 96.91%	1,930 $4,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $29,814 - $47,817	-11,467 Reduced 15.5%	62,490 $190,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $77,826 - $166,344	21,381 Added 40.67%	73,957 $269,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $309,929 - $449,165	51,569 Added 5121.05%	52,576 $413,000
Q2 2021 Aug 16, 2021	SELL	$6.02 - $9.64 $40,496 - $64,848	-6,727 Reduced 86.98%	1,007 $7,000
Q1 2021 May 13, 2021	SELL	$9.17 - $14.8 $193,221 - $311,850	-21,071 Reduced 73.15%	7,734 $73,000
Q4 2020 Feb 09, 2021	BUY	$8.92 - $13.29 $107,914 - $160,782	12,098 Added 72.41%	28,805 $325,000
Q3 2020 Nov 05, 2020	SELL	$9.94 - $16.59 $59,779 - $99,772	-6,014 Reduced 26.47%	16,707 $178,000
Q2 2020 Aug 13, 2020	BUY	$12.07 - $19.34 $80,482 - $128,959	6,668 Added 41.54%	22,721 $346,000
Q1 2020 May 14, 2020	BUY	$12.5 - $22.04 $200,662 - $353,808	16,053 New	16,053 $250,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.